Kukje Pharma Co., Ltd.
Research Kukje Pharma Co., Ltd. (002720.KS) on Bullrun: market cap KRW 87.28B, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker002720.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 87.28B
- Dividend yield0.9%
- Financial periodQ2 2026
- RevenueKRW 48.32B
- Net incomeKRW 1.67B
- Free cash flowKRW 6.54B
- Gross margin55.7%
Valuation Snapshot
latest market cap is KRW 87.28B; dividend yield is 0.9%.
Peer valuation comparison
Latest dividend yield is 0.9% versus a Healthcare sector median of 2.4% (62.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 87.28B | n/a | 0.7% | 30 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 30 KRW, yield 0.9%.
About Kukje Pharma Co., Ltd.
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kukje Pharma Co., Ltd.'s market cap?
Kukje Pharma Co., Ltd.'s market capitalization is KRW 87.28B.
Does Kukje Pharma Co., Ltd. pay a dividend?
Kukje Pharma Co., Ltd. has a dividend yield of 0.9%.
What does Kukje Pharma Co., Ltd. do?
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products.